Supplementary Figures 1-5, and Supplementary Tables 1-3. from KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor
Year: 2023
Type: supplementary-materials
Abstract: Supplementary FIG. 1 IM increases expression of stem markers and decreases KIT in human GIST. Supplementary FIG. 2 Cell cycle analysis of KITHigh and KITLow cells. Supplementary FIG. 3 TKI treatment enriches for KITlow GIST cells additional data. Supplementary FIG. 4 KITlow cells have higher engraftment potential in vivo. Supplementary FIG. 5 Creation of the GIST Onco-GPS map. Supplementary Table 1. Reagent and Oligonucleotides. Supplementary Table 2: GIST-relevant gene sets that provided input genes for the Non-Negative Matrix Factorization (NMF) decomposition. Supplementary Table 3. Antibody screening panel for cell surface markers.
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362614591